{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:28:42Z","timestamp":1790533722771,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Trace Elements in Medicine and Biology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.jtemb.2014.10.001","type":"journal-article","created":{"date-parts":[[2014,10,19]],"date-time":"2014-10-19T11:33:17Z","timestamp":1413718397000},"page":"260-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":170,"special_numbering":"C","title":["Chelation in metal intoxication\u2014Principles and paradigms"],"prefix":"10.1016","volume":"31","author":[{"given":"Jan","family":"Aaseth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit Aralt","family":"Skaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtemb.2014.10.001_bib0005","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/156616a0","article-title":"British anti-lewisite (BAL)","volume":"156","author":"Peters","year":"1945","journal-title":"Nature"},{"issue":"1 Pt 2","key":"10.1016\/j.jtemb.2014.10.001_bib0010","first-page":"175","article-title":"2,3 Dithiolpropanol (BAL\u201d) as a specific detoxifying agent for arsenic","volume":"5","author":"Eagle","year":"1946","journal-title":"Fed Proc"},{"key":"10.1016\/j.jtemb.2014.10.001_bib0015","doi-asserted-by":"crossref","unstructured":"Foreman H, Hamilton JG. The use of chelating agents for accelerating excretion of radioelements. In: University of California Radiation Laboratory UAEC, editor. US Atomic Energy Commission Report. AECD: Oak Ridge, Tenn.; 1951. pp. 1\u201318.","DOI":"10.2172\/1001062"},{"issue":"12","key":"10.1016\/j.jtemb.2014.10.001_bib0020","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1023\/A:1026175825871","article-title":"Interaction between metals and chelating agents affects glutamate binding on brain synaptic membranes","volume":"28","author":"Soares","year":"2003","journal-title":"Neurochem Res"},{"issue":"4","key":"10.1016\/j.jtemb.2014.10.001_bib0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0002-9343(56)90066-3","article-title":"Penicillamine, a new oral therapy for Wilson's disease","volume":"21","author":"Walshe","year":"1956","journal-title":"Am J Med"},{"issue":"8273","key":"10.1016\/j.jtemb.2014.10.001_bib0030","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(82)92201-2","article-title":"Treatment of Wilsons-disease with trientine (Triethylene Tetramine) dihydrochloride","volume":"1","author":"Walshe","year":"1982","journal-title":"Lancet"},{"issue":"5319","key":"10.1016\/j.jtemb.2014.10.001_bib0035","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1136\/bmj.2.5319.1577","article-title":"Iron excretion in thalassaemia major after administration of chelating agents","volume":"2","author":"Smith","year":"1962","journal-title":"Br Med J"},{"issue":"1\u20133","key":"10.1016\/j.jtemb.2014.10.001_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-4274(95)03415-H","article-title":"Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminum chelating drugs","volume":"80","author":"Kontoghiorghes","year":"1995","journal-title":"Toxicol Lett"},{"issue":"2","key":"10.1016\/j.jtemb.2014.10.001_bib0045","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/096032718300200214","article-title":"Recent advance in the therapy of metal poisonings with chelating agents","volume":"2","author":"Aaseth","year":"1983","journal-title":"Hum Toxicol"},{"issue":"Suppl 5","key":"10.1016\/j.jtemb.2014.10.001_bib0050","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1289\/ehp.02110s5887","article-title":"Molecular mechanisms of in vivo metal chelation: implications for clinical treatment of metal intoxications","volume":"110","author":"Andersen","year":"2002","journal-title":"Environ Health Perspect"},{"issue":"3","key":"10.1016\/j.jtemb.2014.10.001_bib0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0016-0032(38)91691-6","article-title":"Acids and bases","volume":"226","author":"Lewis","year":"1938","journal-title":"J Franklin Instit"},{"issue":"4","key":"10.1016\/j.jtemb.2014.10.001_bib0060","first-page":"443","article-title":"Principles of bioinorganic chemistry","volume":"12","author":"Lippard","year":"1995","journal-title":"Nat Product Rep"},{"issue":"22","key":"10.1016\/j.jtemb.2014.10.001_bib0065","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1021\/ja00905a001","article-title":"Hard and soft acids and bases","volume":"85","author":"Pearson","year":"1963","journal-title":"J Am Chem Soc"},{"issue":"1","key":"10.1016\/j.jtemb.2014.10.001_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0362-5478(76)90011-5","article-title":"Pharmacology and therapeutic applications of agents used in heavy-metal poisoning","volume":"1","author":"Catsch","year":"1976","journal-title":"Pharmacol Ther Pt A"},{"issue":"17","key":"10.1016\/j.jtemb.2014.10.001_bib0075","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.2174\/092986712800609742","article-title":"Chelating agents for metal intoxication","volume":"19","author":"Crisponi","year":"2012","journal-title":"Curr Med Chem"},{"issue":"9","key":"10.1016\/j.jtemb.2014.10.001_bib0080","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1021\/cr980453a","article-title":"Principles and recent developments in chelation treatment of metal intoxication","volume":"99","author":"Andersen","year":"1999","journal-title":"Chem Rev"},{"issue":"4","key":"10.1016\/j.jtemb.2014.10.001_bib0085","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1172\/JCI101731","article-title":"Clinical uses of 2,3-dimercaptopropanol (BAL). IV. Pharmacologic observations on BAL by intramuscular injection in man","volume":"25","author":"Modell","year":"1946","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.jtemb.2014.10.001_bib0090","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1067\/mem.2003.72","article-title":"British anti-Lewisite (dimercaprol): an amazing history","volume":"41","author":"Vilensky","year":"2003","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jtemb.2014.10.001_bib0095","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/197084a0","article-title":"Increased uptake of mercury in mouse brain caused by 2,3-dimercaptopropanol","volume":"197","author":"Berlin","year":"1963","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jtemb.2014.10.001_bib0100","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1600-0773.1973.tb01489.x","article-title":"The effect of mercaptodextran on distribution and toxicity of mercury in mice","volume":"32","author":"Aaseth","year":"1973","journal-title":"Acta Pharmacol Tox"},{"key":"10.1016\/j.jtemb.2014.10.001_bib0105","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/978-3-642-74936-0_47","article-title":"Effect of oral treatment with Bal, DMPS or DMSA arsenic in organs of mice injected with arsenic trioxide","volume":"14","author":"Schafer","year":"1991","journal-title":"Arch Toxicol Suppl"},{"issue":"4","key":"10.1016\/j.jtemb.2014.10.001_bib0110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0022-3565(25)03232-X","article-title":"The efficacy of BAL (2,3-dimercaptopropanol) in the treatment of experimental lead poisoning in rabbits","volume":"92","author":"Germuth","year":"1948","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.jtemb.2014.10.001_bib0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jat.2550110103","article-title":"Antidotal effects of dimercaptosuccinic acid","volume":"11","author":"Ding","year":"1991","journal-title":"J Appl Toxicol"},{"issue":"3","key":"10.1016\/j.jtemb.2014.10.001_bib0120","first-page":"273","article-title":"Current status and prevention strategy for coal-arsenic poisoning in Guizhou, China","volume":"24","author":"Li","year":"2006","journal-title":"J Health Popul Nutr"},{"issue":"2","key":"10.1016\/j.jtemb.2014.10.001_bib0125","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0022-3476(94)70217-9","article-title":"Pharmacokinetics of meso-2,3-dimercaptosuccinic acid in patients with lead-poisoning and in healthy-adults","volume":"125","author":"Dart","year":"1994","journal-title":"J Pediatr-Us"},{"issue":"3","key":"10.1016\/j.jtemb.2014.10.001_bib0130","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/bdd.2510030309","article-title":"Pharmacokinetics of C-14-labeled Dmps (sodium-1,3 C-14-2,3-dimercaptopropane-1-Sulphonate) in beagle dogs","volume":"3","author":"Wiedemann","year":"1982","journal-title":"Biopharm Drug Dispos"},{"issue":"2","key":"10.1016\/j.jtemb.2014.10.001_bib0135","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0022-3565(25)12727-4","article-title":"Determination and metabolism of dithiol chelating-agents .10. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma-proteins via mixed disulfide formation","volume":"254","author":"Maiorino","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.jtemb.2014.10.001_bib0140","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0022-3565(25)20546-8","article-title":"Determination and metabolism of dithiol chelating-agents. 12. Metabolism and pharmacokinetics of sodium 2,3-dimercaptopropane-1-sulfonate in humans","volume":"259","author":"Maiorino","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.jtemb.2014.10.001_bib0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1542\/peds.114.1.19","article-title":"Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry","volume":"114","author":"Dietrich","year":"2004","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.jtemb.2014.10.001_bib0150","article-title":"Efficacy of succimer chelation of mercury at background exposures in toddlers: a randomized trial","volume":"158","author":"Cao","year":"2011","journal-title":"J Pediatr-Us"},{"issue":"4","key":"10.1016\/j.jtemb.2014.10.001_bib0155","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1054\/mehy.2000.1281","article-title":"Autism: a novel form of mercury poisoning","volume":"56","author":"Bernard","year":"2001","journal-title":"Med Hypotheses"},{"issue":"6","key":"10.1016\/j.jtemb.2014.10.001_bib0160","first-page":"472","article-title":"Autism, an extreme challenge to integrative medicine. Part 2: medical management","volume":"7","author":"Kidd","year":"2002","journal-title":"Altern Med Rev: J Clin Ther"},{"issue":"Suppl 2","key":"10.1016\/j.jtemb.2014.10.001_bib0165","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1038\/sj.mp.4001176","article-title":"The neuropathogenesis of mercury toxicity","volume":"7","author":"Aschner","year":"2002","journal-title":"Mol Psychiatr"},{"issue":"Pt 1","key":"10.1016\/j.jtemb.2014.10.001_bib0170","first-page":"15","article-title":"Trace element concentrations in hair from autistic children","volume":"29","author":"Wecker","year":"1985","journal-title":"J Ment Defic Res"},{"issue":"1","key":"10.1016\/j.jtemb.2014.10.001_bib0175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.rasd.2012.06.005","article-title":"Chelation treatment for autism spectrum disorders: a systematic review","volume":"7","author":"Davis","year":"2013","journal-title":"Res Autism Spectr Disord"},{"key":"10.1016\/j.jtemb.2014.10.001_bib0420","article-title":"Kill or cure: misuse of chelation therapy for human diseases","author":"Crisponi","year":"2014","journal-title":"Coord Chem Rev"},{"key":"10.1016\/j.jtemb.2014.10.001_bib0185","article-title":"Chelation therapy in intoxications with mercury, lead and copper","author":"Cao","year":"2014","journal-title":"J Trace Elem Med Biol: Organ Soc Miner Trace Elem"},{"issue":"11","key":"10.1016\/j.jtemb.2014.10.001_bib0190","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3200\/AEOH.58.11.701-702","article-title":"Groundwater arsenic contamination in the Ganga-Padma-Meghna-Brahmaputra plain of India and Bangladesh","volume":"58","author":"Sengupta","year":"2003","journal-title":"Arch Environ Health"},{"issue":"7","key":"10.1016\/j.jtemb.2014.10.001_bib0195","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1081\/CLT-100108507","article-title":"Randomized placebo-controlled trial of 2,3-dimercapto-1-propanesulfonate (DMPS) in therapy of chronic arsenicosis due to drinking arsenic-contaminated water","volume":"39","author":"Guha Mazumder","year":"2001","journal-title":"J Toxicol Clin Toxicol"},{"issue":"7","key":"10.1016\/j.jtemb.2014.10.001_bib0200","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3109\/15563659809162616","article-title":"Randomized placebo-controlled trial of 2,3-dimercaptosuccinic acid in therapy of chronic arsenicosis due to drinking arsenic-contaminated subsoil water","volume":"36","author":"Guha Mazumder","year":"1998","journal-title":"J Toxicol Clin Toxicol"},{"issue":"2","key":"10.1016\/j.jtemb.2014.10.001_bib0205","first-page":"355","article-title":"Structural requirements for chelate antidotal efficacy in acute antimony(III) intoxication","volume":"32","author":"Basinger","year":"1981","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.jtemb.2014.10.001_bib0210","series-title":"Metals essentiality, toxicity and selectivity","first-page":"48","article-title":"Clinical chelation: treatment of metal intoxications: principles and recent developments","author":"Andersen","year":"2005"},{"issue":"1","key":"10.1016\/j.jtemb.2014.10.001_bib0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/j.semdp.2008.12.003","article-title":"Death by polonium-210: lessons learned from the murder of former Soviet spy Alexander Litvinenko","volume":"26","author":"McFee","year":"2009","journal-title":"Semin Diagn Pathol"},{"issue":"3","key":"10.1016\/j.jtemb.2014.10.001_bib0220","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s13181-010-0090-x","article-title":"The polonium-210 public health assessment: the need for medical toxicology expertise in radiation terrorism events","volume":"6","author":"Nemhauser","year":"2010","journal-title":"J Med Toxicol"},{"issue":"4","key":"10.1016\/j.jtemb.2014.10.001_bib0225","first-page":"450","article-title":"The effect of BAL on the excretion and tissue distribution of polonium in rats","volume":"103","author":"Hursh","year":"1951","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jtemb.2014.10.001_bib0230","first-page":"54","article-title":"[Characteristics of the distribution and excretion of polonium in animals following the administration of unithiol]","volume":"4","author":"Erleskova","year":"1959","journal-title":"Med Radiol (Mosk)"},{"issue":"1-4","key":"10.1016\/j.jtemb.2014.10.001_bib0235","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/oxfordjournals.rpd.a082299","article-title":"Decorporation of polonium from rats by new chelating-agents","volume":"53","author":"Rencova","year":"1994","journal-title":"Radiat Prot Dosim"},{"key":"10.1016\/j.jtemb.2014.10.001_bib0245","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2261-5-32","article-title":"EDTA chelation therapy for cardiovascular disease: a systematic review","volume":"5","author":"Seely","year":"2005","journal-title":"BMC Cardiovasc Disord"},{"issue":"5","key":"10.1016\/j.jtemb.2014.10.001_bib0250","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/096032719501400504","article-title":"Therapeutic efficacy of combined meso 2,3-dimercaptosuccinic acid and calcium disodium edetate treatment during acute lead intoxication in rats","volume":"14","author":"Flora","year":"1995","journal-title":"Human Exp Toxicol"},{"issue":"2","key":"10.1016\/j.jtemb.2014.10.001_bib0255","first-page":"109","article-title":"EDTA redistribution of lead and cadmium into the soft tissues in a human with a high lead burden - should DMSA always be used to follow EDTA in such cases?","volume":"16","author":"Crinnion","year":"2011","journal-title":"Altern Med Rev: J Clin Ther"},{"issue":"5","key":"10.1016\/j.jtemb.2014.10.001_bib0260","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1021\/tx00041a001","article-title":"Efficacy of combined chelation in lead intoxication","volume":"7","author":"Tandon","year":"1994","journal-title":"Chem Res Toxicol"},{"issue":"6","key":"10.1016\/j.jtemb.2014.10.001_bib0265","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/01.jom.0000204114.01893.3e","article-title":"Effective treatment of manganese-induced occupational Parkinsonism with p-aminosalicylic acid: a case of 17-year follow-up study","volume":"48","author":"Jiang","year":"2006","journal-title":"J Occup Environ Med\/Am College Occup Environ Med"},{"issue":"2","key":"10.1016\/j.jtemb.2014.10.001_bib0270","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.neuro.2008.12.007","article-title":"Chelation therapy of manganese intoxication with para-aminosalicylic acid (PAS) in Sprague\u2013Dawley rats","volume":"30","author":"Zheng","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jtemb.2014.10.001_bib0275","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/03009747909108228","article-title":"Some aspects of the mechanism of action of penicillamine in rheumatoid-arthritis","author":"Munthe","year":"1979","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"10.1016\/j.jtemb.2014.10.001_bib0280","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/00003088-198713050-00003","article-title":"Clinical pharmacokinetics of d-penicillamine","volume":"13","author":"Netter","year":"1987","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jtemb.2014.10.001_bib0285","series-title":"Orphan diseases and orphan drugs","article-title":"The metabolism of trientine: animal studies","author":"Gibbs","year":"1986"},{"issue":"9","key":"10.1016\/j.jtemb.2014.10.001_bib0290","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1158\/1535-7163.MCT-10-0523","article-title":"Triethylenetetramine pharmacology and its clinical applications","volume":"9","author":"Lu","year":"2010","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"10.1016\/j.jtemb.2014.10.001_bib0295","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3748\/wjg.v4.i6.530","article-title":"Comparison of long lasting therapeutic effects between succimer and penicillamine on hepatolenticular degeneration","volume":"4","author":"Ren","year":"1998","journal-title":"World J Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.jtemb.2014.10.001_bib0300","first-page":"S277","article-title":"The metal theory of Alzheimer's disease","volume":"33","author":"Bush","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jtemb.2014.10.001_bib0305","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ica.2012.06.014","article-title":"Metals in the causation and treatment of Wilson's disease and Alzheimer's disease, and copper lowering therapy in medicine","volume":"393","author":"Brewer","year":"2012","journal-title":"Inorg Chim Acta"},{"issue":"5","key":"10.1016\/j.jtemb.2014.10.001_bib0310","first-page":"489","article-title":"Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis","volume":"88","author":"Piga","year":"2003","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.jtemb.2014.10.001_bib0315","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bcmd.2009.01.002","article-title":"Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies","volume":"42","author":"Maggio","year":"2009","journal-title":"Blood Cells Mol Dis"},{"issue":"1","key":"10.1016\/j.jtemb.2014.10.001_bib0320","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-2141.2003.04240.x","article-title":"Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patients","volume":"121","author":"Mourad","year":"2003","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jtemb.2014.10.001_bib0325","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3109\/03630269.2011.576153","article-title":"Efficacy, compliance and toxicity factors are affecting the rate of normalization of body iron stores in thalassemia patients using the deferiprone and deferoxamine combination therapy","volume":"35","author":"Kolnagou","year":"2011","journal-title":"Hemoglobin"},{"issue":"9369","key":"10.1016\/j.jtemb.2014.10.001_bib0330","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(03)13309-0","article-title":"Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial","volume":"361","author":"Nisbet-Brown","year":"2003","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jtemb.2014.10.001_bib0335","first-page":"5A","article-title":"Phase II study of oral chelator ICL670 in thalassaemia patients with transfusional iron overload: Efficacy, safety, pharmacokinetics (PK) and pharmacodynamics (PD) after 6 months of therapy","volume":"100","author":"Piga","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jtemb.2014.10.001_bib0340","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0091270003043006002","article-title":"Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia","volume":"43","author":"Galanello","year":"2003","journal-title":"J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.jtemb.2014.10.001_bib0345","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1182\/blood-2009-04-217455","article-title":"Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia","volume":"115","author":"Pennell","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtemb.2014.10.001_bib0350","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.beha.2004.09.002","article-title":"Iron-chelating therapy with the new oral agent ICL670 (Exjadee((R)))","volume":"18","author":"Cappellini","year":"2005","journal-title":"Best Pract Res Cl Ha"},{"issue":"1","key":"10.1016\/j.jtemb.2014.10.001_bib0355","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3324\/haematol.2009.019042","article-title":"Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging","volume":"96","author":"Pepe","year":"2011","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.jtemb.2014.10.001_bib0360","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/14740338.6.3.235","article-title":"Deferasirox: uncertain future following renal failure fatalities, agranulocytosis and other toxicities","volume":"6","author":"Kontoghiorghes","year":"2007","journal-title":"Expert Opin Drug Saf"},{"issue":"12","key":"10.1016\/j.jtemb.2014.10.001_bib0365","doi-asserted-by":"crossref","first-page":"e82662","DOI":"10.1371\/journal.pone.0082662","article-title":"Comparative efficacy and safety of deferoxamine, deferiprone and deferasirox on severe thalassemia: a meta-analysis of 16 randomized controlled trials","volume":"8","author":"Xia","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jtemb.2014.10.001_bib0370","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1139\/Y09-128","article-title":"Iron redistribution as a therapeutic strategy for treating diseases of localized iron accumulation","volume":"88","author":"Kakhlon","year":"2010","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.jtemb.2014.10.001_bib0375","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.freeradbiomed.2013.01.017","article-title":"Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators","volume":"62","author":"Weinreb","year":"2013","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"10.1016\/j.jtemb.2014.10.001_bib0380","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/jmri.21563","article-title":"MRI assessment of basal ganglia iron deposition in parkinson's disease","volume":"28","author":"Wallis","year":"2008","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"10.1016\/j.jtemb.2014.10.001_bib0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15376516.2012.720305","volume":"23","author":"Kontoghiorghes","year":"2013","journal-title":"Toxicol Mech Methods"},{"issue":"8","key":"10.1016\/j.jtemb.2014.10.001_bib0390","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1089\/ars.2012.4540","article-title":"Novel chelators for cancer treatment: where are we now?","volume":"18","author":"Merlot","year":"2013","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"10.1016\/j.jtemb.2014.10.001_bib0395","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0041-008X(76)90008-9","article-title":"Acute systemic toxicity of pure dimercaprol and trimercaptopropane","volume":"36","author":"Zvirblis","year":"1976","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2 Pt 2","key":"10.1016\/j.jtemb.2014.10.001_bib0400","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/0272-0590(84)90138-6","article-title":"DMSA, DMPS, and DMPA\u2014as arsenic antidotes","volume":"4","author":"Aposhian","year":"1984","journal-title":"Fundam Appl Toxicol"},{"key":"10.1016\/j.jtemb.2014.10.001_bib0405","unstructured":"Lewis R, Tatken R. Registry of toxic effects of chemical substances. Services UDoHaH, editor. 1980."},{"issue":"3","key":"10.1016\/j.jtemb.2014.10.001_bib0410","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0041-008X(81)90098-3","article-title":"Comparison of the effectiveness of several chelators after single administration on the toxicity, excretion, and distribution of cadmium","volume":"58","author":"Cantilena","year":"1981","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jtemb.2014.10.001_bib0415","unstructured":"Ciba-Geygy. Product monograph on desferrioxamine. 1994."}],"container-title":["Journal of Trace Elements in Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0946672X14001801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0946672X14001801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T02:32:24Z","timestamp":1746412344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0946672X14001801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":82,"alternative-id":["S0946672X14001801"],"URL":"https:\/\/doi.org\/10.1016\/j.jtemb.2014.10.001","relation":{},"ISSN":["0946-672X"],"issn-type":[{"value":"0946-672X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chelation in metal intoxication\u2014Principles and paradigms","name":"articletitle","label":"Article Title"},{"value":"Journal of Trace Elements in Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtemb.2014.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}